Skip Navigation
National Institute of Environmental Health SciencesNational Institutes of Health
Increase text size Decrease text size Print this page

Related Publications

  1. Klein RQ, Bangert CA, Costner M, Connolly MK, Tanikawa A, Okawa J, Rose M, Fakharzadeh SS, Fiorentino D, Lee LA, Sontheimer RD, Taylor L, Troxel AB, Werth VP, Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis, Br J Dermatol, 2008 Sep 159(4):887-94. Epub 2008 Jul 4
    Pub Med (http://www.ncbi.nlm.nih.gov/pubmed/18616782?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum)
  2. Huber AM, Lachenbruch PA, Dugan EM, Miller FW, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group, Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats, Arthritis Rheum, 2008 Mar 15 59(3):352-6
    Pub Med (http://www.ncbi.nlm.nih.gov/pubmed/18311761?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum)
  3. Huber AM, Dugan EM, Lachenbruch PA, Feldman BM, Perez MD, Zemel LS, Lindsley CB, Rennebohm RM, Wallace CA, Passo MH, Reed AM, Bowyer SL, Ballinger SH, Miller FW, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group, Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis, Arthritis Rheum, 2008 Feb 15 59(2):214-21
    Pub Med (http://www.ncbi.nlm.nih.gov/pubmed/18240194?ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum)
  4. Ruperto N, Ravelli A, Pistorio A, Ferriani V, Calvo I, Ganser G, Brunner J, Dannecker G, Silva CA, Stanevicha V, Cate RT, van Suijlekom-Smit LW, Voygioyka O, Fischbach M, Foeldvari I, Hilario O, Modesto C, Saurenmann RK, Sauvain MJ, Scheibel I, Sommelet D, Tambic-Bukovac L, Barcellona R, Brik R, Ehl S, Jovanovic M, Rovensky J, Bagnasco F, Lovell DJ, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG), The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study, Arthritis Rheum, 2008 Jan 15 59(1):4-13
    Pub Med (http://www.ncbi.nlm.nih.gov/pubmed/18163404?ordinalpos=11&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum)
  5. Huber AM, Dugan EM, Lachenbruch PA, Feldman BM, Perez MD, Zemel LS, Lindsley CB, Rennebohm RM, Wallace CA, Passo MH, Reed AM, Bowyer SL, Ballinger SH, Miller FW, Rider LG; in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy. Rheumatology (Oxford). 2007 Oct;46(10):1606-11.
    Pub Med (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17890275&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.) Exit NIEHS
  6. Wedderburn LR, Varsani H, Li CK, Newton KR, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith A, Harding B, Hoogendijk J, Lundberg IE, Marie S, Minetti C, Nennesmo I, Rushing EJ, Sewry C, Charman SC, Pilkington CA, Holton JL; UK Juvenile Dermatomyositis Research Group. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum. 2007 Oct 15;57(7):1192-201.
    Pub Med (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17907237&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum) Exit NIEHS
    8. Stone KB, Oddis CV, Fertig N, Katsumata Y, Lucas M, Vogt M, Domsic R, Ascherman DP. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum. 2007 Sep;56(9):3125-31.
    Pub Med (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17763431&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum) Exit NIEHS
  8. Alexanderson H, Broman L, Tollback A, Josefson A, Lundberg IE, Stenstrom CH. Functional index-2: Validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis. Arthritis Rheum. 2006 Feb 15;55(1):114-22.
    Pub Med (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16463422&ordinalpos=31&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum) Exit NIEHS
  9. Chung YL, Rider LG, Bell JD, Summers RM, Zemel LS, Rennebohm RM, Passo MH, Hicks J, Miller FW, Scott DL; Juvenile Dermatomyositis Disease Activity Collaborative Study Group, Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies, Arthritis Rheum. 2005 Aug 15;53(4):565-70.
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16082628&query_hl=3) Exit NIEHS
  10. Ponyi A, Borgulya G, Constantin T, Vancsa A, Gergely L, Danko K, Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis, Rheumatology (Oxford), 2005 Jan;44(1):83-8. Epub 2004 Sep 20,
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15381789) Exit NIEHS
  11. Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, Zemel LS, Wallace CA, Ballinger SH, Passo MH, Reed AM, Summers RM, White PH, Katona IM, Miller FW, Lachenbruch PA, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group, Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies, Arthritis Rheum., 2004 May, 50(5):1595-603
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15146430) Exit NIEHS
  12. Rennebohm RM, Jones K, Huber AM, Ballinger SH, Bowyer SL, Feldman BM, Hicks J, Katona IM, Lindsley CB, Miller FW, Passo MH, Perez MD, Reed AM, Wallace CA, White PH, Zemel LS, Lachenbruch PA, Hayes JR, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group, Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale, Arthritis Rheum., 2004 Jun 15, 51(3):365-70
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15188320) Exit NIEHS
  13. Miller FW, Rider LG, Plotz PH, Rutkove SB, Pestronk A, Wortmann RL, Lundberg IE, Argov Z, Isenberg DA, Lacomis D, Oddis CV, Polymyositis: an overdiagnosed entity, Neurology, 2004 Jul 27, 63(2):402
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15277657) Exit NIEHS
  14. Smith RL, Sundberg J, Shamiyah E, Dyer A, Pachman LM, Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops, J Rheumatol., 2004 Aug, 31(8):1644-9
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15290747) Exit NIEHS
  15. Miller FW, Rider LG, Plotz PH, Isenberg DA, Oddis CV, Diagnostic criteria for polymyositis and dermatomyositis, Lancet, 2003 Nov 22, 362(9397):1762-3; author reply 1763
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14643132) Exit NIEHS
  16. Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM, Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence, Arthritis Rheum., 2003 Feb 15, 49(1):7-15
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12579588) Exit NIEHS
  17. Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A; Paediatric Rheumatology International Trials Organization (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG), Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis, Rheumatology (Oxford), 2003 Dec, 42(12):1452-9. Epub 2003 Jun 27
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12832713) Exit NIEHS
  18. Sultan SM, Ioannou Y, Moss K, Isenberg DA, Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality, Rheumatology (Oxford), 2002 Jan, 41(1):22-6
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11792875) Exit NIEHS
  19. Rider LG*, AS Schiffenbauer*, M Zito, KL Lim, A Ahmed, LS Zemel, RM Rennebohm, MH Passo, RM Summers, JE Hicks, PA Lachenbruch, MP Heyes, FW Miller, in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group, Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies, Clin. Chem., 2002, 48:1681 - 1688; *These authors contributed equally.
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12324484) Exit NIEHS
  20. Huber A, J.E. Hicks, P.A. Lachenbruch, M.D. Perez, L.S. Zemel, R.M. Rennebohm, C.A. Wallace, C.B. Lindsley, M.H. Passo, S.H. Ballinger, S.L. Bowyer, A.M., P.H. White, I.M. Katona, F.W. Miller, L.G. Rider*, and B.M. Feldman*, Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. III. The Childhood Health Assessment Questionnaire (CHAQ), J Rheumatology, 2001, 28:1106-1111; *These authors contributed equally
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11361197) Exit NIEHS
  21. Lovell D.J., CB. Lindsley, RM. Rennebohm, SH. Ballinger, SL. Bowyer, EH Giannini, JE Hicks, JE Levinson, R. Mier, LM Pachman, MH Passo, MD Perez, AM Reed, KN Schickler, M. Smith, LS Zemel, LG Rider, in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group, Development of validated disease activity and disease damage indices for the juvenile idiopathic inflammatory myopathies: II. The Childhood Myositis Assessment Scale: A quantitative tool for the evaluation of muscle function, Arthritis Rheumatism, 1999, 42:2213-2219
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10524696) Exit NIEHS
  22. Rider, L.G., B.M. Feldman, M.D. Perez, R.M. Rennebohm, C.B. Lindsley, L.S. Zemel, C.A. Wallace, S.H. Ballinger, S.L. Bowyer, A.M. Reed, M.H. Passo, I.M. Katona, F.W. Miller, and P.A. Lachenbruch, for the Juvenile Dermatomyositis Disease Activity Collaborative Study Group, Development of Validated Disease Activity and Disease Damage Indices for the Juvenile Idiopathic Inflammatory Myopathies: I. Physician and Parent/Patient Global Assessments, Arthritis Rheumatism, 1997, 40: 1976-1983
    Pub Med (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9365086) Exit NIEHS
USA.gov Department of Health & Human Services National Institutes of Health
This page URL: http://www.niehs.nih.gov/research/resources/collab/imacs/relatedpubs.cfm
NIEHS website: http://www.niehs.nih.gov/
Email the Web Manager at webmanager@niehs.nih.gov
Last Reviewed: October 30, 2007